FF 10-K & 10-Q changes, risk factors and insider trading
FutureFuel Corp. · NYSE · Industrial Organic Chemicals · CIK 1337298 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Risk Factors
New heading “Currently, there is a supply disruption in the renewable fuel market as proposed regulations are finalized on the CFPC. However, under normal conditions there is excess renewable fuel production capacity and low utilization in the industry and if non-operational and underused facilities commence or increase operations, our results of operations may be negatively affected.”
New heading “We are subject to industry and economic conditions that have caused several biofuel companies throughout the United States to file for bankruptcy over the last several years.”
New heading “Risks Related to Emerging Technologies and Artificial Intelligence”
Removed heading “There is disruption in supply in the renewable fuel market currently without clarity on the CFPT credit. However, under normal conditions there is excess renewable fuel production capacity and low utilization in the industry and if non-operational and underused facilities commence or increase operations, our results of operations may be negatively affected.”
Removed heading “Several biofuel companies throughout the United States have filed for bankruptcy over the last several years due to industry and economic conditions.”
Largest changes
“We are subject to industry and economic conditions that have caused several biofuel companies throughout the United States to file for bankruptcy over the last several years.”see in full comparison
“Several biofuel companies throughout the United States have filed for bankruptcy over the last several years due to industry and economic conditions.”see in full comparison
“Currently, there is a supply disruption in the renewable fuel market as proposed regulations are finalized on the CFPC. However, under normal conditions there is excess renewable fuel production capacity and low utilization in the industry and if non-operational and underused facilities commence or increase operations, our results of operations may be negatively affected.”see in full comparison
“Improper use of generative AI and LLMs could result in a material adverse effect on our operations and financial results. Employees may engage in the horizontal use of generative AI and LLMs. Such use, if not properly governed, carries risks of “Shadow AI'” — the use of unsanctioned tools that may lead to the unauthorized disclosure of proprietary chemical formulas, trade secrets, or personal information. …”see in full comparison
“Risks Related to Emerging Technologies and Artificial Intelligence”see in full comparison
“There is disruption in supply in the renewable fuel market currently without clarity on the CFPT credit. However, under normal conditions there is excess renewable fuel production capacity and low utilization in the industry and if non-operational and underused facilities commence or increase operations, our results of operations may be negatively affected.”see in full comparison
Full comparison: every changed paragraph (24)
We are subject to various U.S. and global economic conditions, including our sourcing of certain raw materials for our chemicals segment internationally. Accordingly, adverse changes in these conditions, including supply chain disruptions and price inflation for those raw materials, which can adversely impact our business. The impacts include, but are not limited to:
Historically, the most significant tax incentive program in the biomass-based diesel industry hashad been the BTC. Under the BTC, the first market participant to blend pure biomass-based diesel with petroleum-based diesel fuel receivesreceived a one dollar per gallon refundable tax credit. From time to time, the BTC has expired and been retroactively reinstated. Most recently, the Inflation Reduction Act, adopted in August 2022, extended the BTC through December 31, 2024, but provided for its replacement by the CFPC on January 1, 2025. The CFPC is structured on a sliding scale so that producers become eligible for larger credits as the GHG emissions of the fuels they produce approach zero. For producers meeting prevailing wage and registered apprenticeship requirements, the maximum credit is $1.00 per gallon of biodiesel. However, the maximum credit would require zero GHG emissions which is unrealistic for almost every biodiesel producer, including the Company. Guidance surrounding this credit haswas yetproposed toon beFebruary finalized3, despite2026, theand effectiveis dateawaiting ofpublic the CFPC.comment. Given our relative position to other biodiesel producers and the importance of such incentives to our operations, a reduction or elimination of these governmental incentives could have a material adverse effect on us and on the biodiesel industry in general. Specifically, if biodiesel prices decrease as a result of the expiration or significant reduction in these governmental incentives and biodiesel feedstock costs do not decrease proportionately, we could realize a negative gross margin on biodiesel. As a result, we could be forced to cease production of biodiesel, which would have an adverse effect on our financial condition.
With respect to our biofuels platform, the United States Congress could repeal, curtail or otherwise change the RFS2 program in a manner adverse to us. Similarly, the USEPA could curtail or otherwise change its administration of the RFS2 program in a manner adverse to us, including by not increasing or even decreasing the required renewable fuel volumes, by waiving compliance with the required renewable fuel volumes or otherwise. In addition, while Congress specified RFS2 renewable fuel volume requirements through 2022 (subject to adjustment in the rulemaking process), beginning in 2023 required volumes of renewable fuel will beare largely at the discretion of the USEPA (in coordination with the Secretary of Energy and Secretary of Agriculture). We cannot predict what changes, if any, will be instituted or the impact of any changes on our business, although adverse changes could seriously harm our revenues, earnings and financial condition.
We have historically derived a significant portion of our revenues from sales of our biofuels in the State of California primarily as a result of California’s Low Carbon Fuel Standard (“LCFS”); adverse changes in this law or reductions in the value of LCFS credits would harm our revenues and profits.
The biodiesel and specialty chemical industries are highly competitive. There is competition within these industries and also with other industries in supplying the energy, fuel, and chemical needs of industry and individual customers. We compete with other firms in the sale or purchase of various goods or services in many national and international markets. We compete with large national and multi-national companies that have longer operating histories, greater financial, technical, and other resources, and greater name recognition than we do. In addition, we compete with several smaller companies capable of competing effectively on a regional or local basis. Our competitors may be able to respond more quickly to new or emerging technologies and services and changes in customer requirements. As a result of competition, we may lose market share or be unable to maintain or increase prices for our products and/or services or to acquire additional business opportunities, which could have a material adverse effect on our business, financial condition, results of operations, and cash flows. Although we will employ all methods of competition that arewe lawful anddeem appropriate for such purposes, no assurances can be made that they will be successful. A key component of our competitive position, particularly given the commodity-based nature of many of our products, will be our ability to manage expenses successfully, which requires continuous management focus on reducing unit costs and improving efficiency. No assurances can be given that we will be able to successfully manage such expenses.
The total current U.S. production capacity for biodiesel iswas in excess of the current RFS2 mandate for 20232024 and 2024.2025. Excess production capacity over the annual mandates could result in a decline in biodiesel prices and profitability, negatively impacting our ability to maintain the profitability of our biofuels segment and recover capital expenditures in this business segment.
Disruptions could also occur due to internal factors such as computer or equipment malfunction (accidental or intentional), operator error, or process failures; or external factors such as computer or equipment malfunction at third-party service providers, natural disasters, pandemic illness, changes in laws or regulations, war or other outbreak of hostilities or terrorism, cyber-incidents, or breakdown or degradation of transportation infrastructure used for delivery of supplies to the Company or for delivery of products to customers. We have recently suffered increasingly frequent, unscheduled and extended service utility downtime as a result of supplier delays and quality issues beyond our control.control which may be exacerbated by cyber-incidents affecting those third-party providers. Furthermore, many of our manufacturing control systems rely on legacy hardware and software that may no longer be supported by original equipment manufacturers. This creates risks related to the availability of replacement parts, specialized repair expertise, and the inability to apply modern security patches. Because many of these systems operate on single-processor architectures without redundancy, any maintenance or repair requires total system downtime, which may be difficult to schedule without impacting production commitments. No assurances can be provided that any future disruptions due to these, or other, circumstances will not have a material effect on operations. Such disruptions could result in an unplanned event that could be significant in scale and could negatively impact operations, neighbors, and the environment, and could have a negative impact on our results of operations.
Our chemical business is concentrated with fourthree large customers covering multiple products representing greater than 84%81% of our chemicals segment product sales, or 28%50% of total revenues. Although this business is contracted in longer-term production agreements, the loss of any of these strategic customers could have a material adverse effect on our chemicals business.
Additionally, our biofuels segment has two large customers. We do not believe that the loss of these customers would have a material adverse effect on our biofuels segment or on us as a whole in that: (i) unlike our custom manufacturing products, biodiesel is a commodity with a large potential customer base; (ii) we believe that we could readily sell our biodiesel to other customers as potential demand from other customers for biodiesel exceeds our production capacity; (iii) our sales to these customers are not under fixed terms and the customers have no fixed obligation to purchase any minimum quantities except as stipulated by short term purchase orders; and (iv) the prices we receive from these customers are based upon then-market rates, as would be the case with sales of this commodity to other customers.
Sales to these biodiesel customers totaled approximately 25%38% of total revenue (or $59,867,000$36,178) in 2024.2025. No biofuel customer in 2025 was greater than 10% of total revenue. Sales in 20232024 to our two largest customers represented 35%25% of total revenues (or $127,763,000$59,867). Sales to our two largest biodiesel customers totaled 27%35% of total revenues in 20222023 (or $107,898,000$127,763). We do not have a contractcontracts with these customerscustomers, but rather sell based on monthly or short-term, multi-month purchase orders placed with us by the customers at prices based upon then-prevailing market rates.
We do not believe that the loss of these large, concentrated customers would have a material adverse effect on our biofuels segment or on us as a whole in that: (i) unlike our custom manufacturing products, biodiesel is a commodity with a large potential customer base; (ii) we believe that we could readily sell our biodiesel to other customers as potential demand from other customers for biodiesel exceeds our production capacity; (iii) our sales to these customers are not under fixed terms and the customers have no fixed obligation to purchase any minimum quantities except as stipulated by short term purchase orders; and (iv) the prices we receive from these customers are based upon then-market rates, as would be the case with sales of this commodity to other customers.
Currently, there is a supply disruption in the renewable fuel market as proposed regulations are finalized on the CFPC. However, under normal conditions there is excess renewable fuel production capacity and low utilization in the industry and if non-operational and underused facilities commence or increase operations, our results of operations may be negatively affected.
The transition from the BTC to the CFPC under Section 45Z redefined the competitive landscape for the 2025 fiscal year. While this shift provides a production-based incentive, it also introduces specific operational risks related to market saturation and feedstock availability. Historically, the renewable fuel industry has been characterized by significant excess production capacity and low utilization rates. In 2024, many biodiesel plants were sidelined or operated at reduced levels due to regulatory uncertainty. In early 2025, with the implementation of the CFPC, many of these non-operational or underused facilities commenced or increased operations. This surge in active capacity poses several risks:
The reactivation of dormant capacity has intensified the competition for key feedstocks (such as soybean oil, corn oil, and tallow).
We are subject to industry and economic conditions that have caused several biofuel companies throughout the United States to file for bankruptcy over the last several years.
We holdhave entered into a $75$35 million revolving credit facility with a commercial bank. This credit facility expires in February 2030. Although as of the date of this report we have no outstanding borrowings under the existing facility, if and when we do borrow, the restrictions governing this type of indebtedness (such as limitations on the ratio of our total debt to EBITDA limitations) could reduce our ability to incur additional indebtedness, engage in certain transactions, or capitalize on acquisition or other business opportunities.
The Company has information and information processing assets, including intellectual property, trade secrets, and other sensitive, business critical information as well as on-premises and cloud-based business applications critical to conducting business. In addition, our chemical manufacturing facilities are highly automated using a mix of legacy and modern computercomputerized systems.Industrial Control Systems (“ICS”). These legacy systems, while functional for production, often lack modern security features and may be more susceptible to vulnerabilities that cannot be mitigated through standard IT security protocols. Cyber-incidents affecting the Company, its supply chainchain, utility providers or customers could compromise confidential, business critical information, cause a sustained disruption in the Company’s operations, harm the Company's reputation, or lead to a loss of control of physical processes that could endanger the environment if the Company, its suppliers or customers do not effectively prevent, detect and recover from these or other security breaches. The Company, like many companies today, is the target of industrial espionage, including cyber-attacks. TheWhile the Company hascontinuously determinedmonitors thatfor unauthorized activity, these cyber-attacksincreasingly have resulted,sophisticated and couldautomated threats may result in the future, in unauthorized parties gaining access to certain confidential business information.information Whenor seeking to gain lateral access to manufacturing control networks. In instances where potential unauthorized access is discovered,identified, the Company reportsinitiates suchits situationsincident response plan to investigate, mitigate, and, where appropriate, report to governmental authorities for investigation, as appropriate, and takes measures to mitigate any potential impact.authorities.
Although management does not believe that the Company has experienced any material losses to date related to these cyber security incidents, there can be no assurance that such losses will not be suffered in the future. The Company seeks to actively manage the risks within its control that could lead to business disruptions and cyber security incidents through a comprehensive cyber security program and structured management of change processes that isare continuously reviewed (through internal and third-party auditing), maintained, and upgraded. As these threats continue to evolve, particularly around cybersecurity, the Company may be required to expend significant resources to enhance its control environment, processes, practices, and other protective measures. Despite these efforts, such events could have a material adverse effect on the Company’s business, results of operations, financial condition and cash flows.
Risks Related to Emerging Technologies and Artificial Intelligence
Improper use of generative AI and LLMs could result in a material adverse effect on our operations and financial results. Employees may engage in the horizontal use of generative AI and LLMs. Such use, if not properly governed, carries risks of “Shadow AI'” — the use of unsanctioned tools that may lead to the unauthorized disclosure of proprietary chemical formulas, trade secrets, or personal information. Furthermore, reliance on AI-generated output that contains “hallucinations” or technical inaccuracies could, if not verified by subject matter experts, result in process safety incidents or inaccurate regulatory reporting, which could have a material adverse effect on the Company’s business and operations, results of operations, financial condition and cash flows.
There is disruption in supply in the renewable fuel market currently without clarity on the CFPT credit. However, under normal conditions there is excess renewable fuel production capacity and low utilization in the industry and if non-operational and underused facilities commence or increase operations, our results of operations may be negatively affected.
Many biodiesel plants in the United States are currently shutdown without clarity on the CFPT credit. Most biodiesel plants, when running, do not operate at full capacity. Further, a number of renewable diesel plants are under construction in the United States as of December 2024, and if completed, would add additional renewable fuel production capacity. The annual production capacity of existing plants and plants under construction far exceeds both historic consumption of renewable fuels in the United States and required consumption under RFS2. If this excess production capacity was used, it would increase competition for our feedstocks, increase the volume of renewable fuels on the market, and may reduce our biodiesel gross margins, harming our revenues and profitability.
Several biofuel companies throughout the United States have filed for bankruptcy over the last several years due to industry and economic conditions.
The market price of our common stock is highly volatile, and our shares are thinly traded. Our stock price may change dramatically as the result of: (i) announcements of new products or innovations by us or our competitors; (ii) uncertainty regarding the viability of any of our product initiatives; (iii) significant customer contracts; (iv) significant litigation; (v) uncertainty with respect to changing laws and regulations that impact our business and our ability to take advantage of tax credits such as the BTC and CFPC; or (vi) unscheduled and extended downtime at our facility; or (vii) events that would be expected to affect our business, financial condition, results of operations, and future prospects.
Management's Discussion & Analysis (MD&A)
New heading “Biofuels Segment Revenue Impact”
New heading “Chemicals Segment Revenue Impact”
New heading “Segment Contributions to Gross Profit Decline”
New heading “Custom Chemicals”
New heading “Performance Chemicals”
New heading “Depreciation Methodology”
Removed heading “2023 Compared to 2022”
Removed heading “2023 Compared to 2022”
Removed heading “2023 Compared to 2022”
Largest changes
“Customer Concentration and Market Dynamics. Historically, a portion of our biodiesel output was sold to two major United States refiners. In 2025, however, we had no major customers with revenue greater than 10%.”see in full comparison
“A portion of our biodiesel sold was to two major refiners in the United States in 2024 and 2023. No assurances can be given that we will continue to sell to such major refiners, or, if we do sell, the volume we will sell or the profit margin we will realize. …”see in full comparison
“A portion of our biodiesel sold was to two major refiners in the United States in 2023 and 2022. No assurances can be given that we will continue to sell to such major refiners, or, if we do sell, the volume we will sell or the profit margin we will realize. …”see in full comparison
Full comparison: every changed paragraph (76)
The following Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read together with our consolidated financial statements, including the Notes thereto, set forth herein. Further, for additional discussion of our results for 2024, compared to 2023, please see “Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on March 31, 2025, which discussion is incorporated herein by reference and which is available through the SEC’s official website at www.sec.gov and through the “Investors” section of the Company’s website (https://futurefuel-corporation.ir.rdgfilings.com).
The following Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read together with our consolidated financial statements, including the Notes thereto, set forth herein.
There remains significant uncertainty regarding our future biodiesel production volumes. This outlook is primarily driven by the volatility of feedstock prices relative to finished biodiesel market prices and a systemic lack of permanency in critical government mandates. Our operational strategy is heavily dependent on federal and state incentive structures, which are subject to legislative change or expiration. Key factors contributing to this uncertainty include:
Furthermore, government mandates have increasingly strengthened competing sectors, creating headwinds for our biodiesel operations. These include:
For a detailed analysis of these variables, please refer to "Risk Factors" and Note 3 of our consolidated financial statements.
There currently is uncertainty as to our production of biodiesel in the future. This uncertainty results from changes in feedstock prices relative to biodiesel prices and the lack of permanency of government mandates including the BTC, the small producer’s tax credit, the CFPC (effective January 1, 2025), the renewable fuels program, and the California low carbon fuel program credits. See “Risk Factors” above as well as Note 3 to our consolidated financial statements. This uncertainty also results from government mandates that strengthen markets that we compete against including renewable diesel and electric vehicles.
While biodiesel is the principal component of the biofuels segment, we also generate revenue from the sale of petrodiesel both in blends with our biodiesel and, from time to time, with no biodiesel added. PetrodieselWe have both truck and biodieselrail blends are available to customers at our leased storage facility in North Little Rock, Arkansas andaccess at our Batesville plant.facility. In addition, we deliver blended product to a small group of customers within our region.region, Weand alsofrom time to time, sell D4 and D6 RINs from time to time.RINs. At December 31, 20242025, we held 3.10.4 million RINs with a market value of $1,831$379 and at December 31, 2023,2024, we held 4.33.1 million RINs in inventory with a market value of $6,567.$1,831.
The majority of our expenses are cost of goods sold. Cost of goods sold includes raw material costs as well as both fixed and variable conversion costs, such conversion costs being those expenses that are directly or indirectly related to the operation of our plant. Significant conversion costs include labor, benefits, energy, supplies, depreciation, and maintenance and repair. In addition to raw material and conversion costs, cost of goods sold includes environmental reserves and costs related to idle capacity. Finally, cost of goods sold includes hedging gains and losses recognized by us related to our biofuels segment. Cost of goods sold is allocated to the chemicalsChemicals and biofuels businessBiofuels segments based on equipment and resource usage for most conversion costs and based on revenue for most other costs.
For the fiscal year ended December 31, 2025, consolidated revenue decreased 61% ($147,597) compared to 2024. This significant contraction was primarily driven by severe regulatory headwinds in the Biofuels segment and operational interruptions within the Chemicals segment.
Biofuels Segment Revenue Impact
The Biofuels segment was the primary driver of the consolidated revenue decline, contributing $127,155 of the total decrease ($122,836 from lower volumes and $4,319 from lower pricing).
Chemicals Segment Revenue Impact
The Chemicals segment contributed $20,442 to the consolidated revenue decrease, driven by:
Consolidated gross profit decreased by $59,069 in 2025 compared to the prior year. This margin compression was driven by a confluence of regulatory headwinds, operational interruptions, and the expiration of legacy contractual benefits.
Segment Contributions to Gross Profit Decline
Primary Drivers of the Decrease. The year-over-year reduction in profitability was primarily influenced by:
Mitigating Factors. The overall decline was partially offset by a favorable swing in the change in derivatives. The unrealized activity of derivative instruments yielded a gain of $221 in 2025, compared to a loss of $1,971 in the prior year.
Consolidated sales revenue decreased 34% or $124,911 in 2024 compared to 2023 from lower sales volumes ($60,574) and lower prices ($65,011) in the biofuel segment. Partially offsetting this decline was an increase in chemical segment volumes and an increase of $5,492 in amortization of deferred revenue from the expiration of a long-term contract which is now a short-term contract.
Gross profit decreased 52% or $21,335 in 2024 compared to 2023. This comparative decrease was ($14,031) in the biofuel segment and ($7,304) in the chemical segment. This reduction was inclusive of (i) reduced sales volumes of biodiesel and glycerin from extreme weather conditions in the first three months of the year, ii) downtime of both biodiesel and chemical production equipment during the last half of 2024 from delays by equipment suppliers, and iii) in the biofuel segment, the change in the unrealized activity of derivative instruments in comparison to the prior year with a loss of $1,971 in the current year and a gain of $1,878 in the prior year. Also contributing to this reduced margin was the change in adjustments in the carrying value of our inventory as determined utilizing the LIFO method of inventory accounting which increased gross profit $3,028 in 2024 as compared to $10,334 in 2023. Partially offsetting this decrease was the benefit of the amortization of deferred revenue in the chemical segment of $5,492.
Operating expenses decreased $339 in 2024 compared to 2023. This decrease was primarily the result of decreased research and development and legal expenses.
Other income decreased $92 in 2024 as compared to 2023. This net decrease was due to (i) the reduction of interest income of $1,921, (ii) the prior year gain of $575 on the sale of marketable securities with no such gain in the current year, and (iii) separations payments made in the current year. These reductions were mostly offset by the receipt of a $2,750 settlement in 2024 (see Note 22 of our consolidated financial statements for further details).
The income tax provision was $792 in 2024 or an effective tax rate of 4.9% as compared to a provision in 2023 of $1 or an effective tax rate of 0.0%.
The Company’s effective tax rates for the years 2024 and 2023 reflect the positive effect of certain tax credits and incentives, the most significant of which are the BTC and the Small Agri-biodiesel Producer Tax Credit. Based on technical guidance from the Internal Revenue Service, the Company excludes the portion of the BTC not used to satisfy excise tax liabilities from income. See Note 3 to our consolidated financial statements for a discussion of the pretax earnings impact of the BTC.
The Company’s effective tax rate for 2024 and 2023 includes an expense of $8,169 or 50.1% and $6,821 or 18.2%, respectively, from the recording of a valuation allowance against its deferred tax assets. The Company evaluates its deferred tax assets and records a valuation allowance to reduce these assets to the amount that is more likely than not to be realized. As of December 31, 2024, based on all available and allowable evidence, the Company determined that its deferred tax assets of $41,076 are more likely than not realizable only to the extent of $18,691, resulting in a net deferred tax liability of $773. As of December 31, 2023, based on all available and allowable evidence, the Company determined that its deferred tax assets were more likely than not realizable only to the extent of its deferred tax liabilities and recorded the resulting valuation allowance.
The Company’s unrecognized tax benefit totaled $0 at December 31, 2024 and 2023.
2023 Compared to 2022
Consolidated sales revenue decreased 7.0% or $27,764 in 2023 compared to 2022 primarily from lower average sales prices in the biofuel segment ($71,198) and, to a lesser extent, in the chemical segment ($1,916). This decrease was partially offset by higher biodiesel sales volumes in the biofuel segment ($44,994).
Gross profit increased 41.3% or $11,986 in 2023 compared to 2022. This comparative increase was primarily attributable to improved margins in both the biofuel and chemical segments inclusive of (i) the change in the realized activity of derivative instruments in comparison to the prior year with a gain of $694 as compared to a loss of $24,703 in the prior year; the prior year loss included an unfavorable impact of volatility in the NYMEX heating oil futures market of $10,500 and (ii) the change in the unrealized activity of derivative instruments in comparison to the prior year with a gain of $1,878 in the current year and a gain of $343 in the prior year. Also contributing to this improved margin was the benefit from the change in adjustments in the carrying value of our inventory as determined utilizing the LIFO method of inventory accounting which increased gross profit $10,334 in 2023 and decreased gross profit $3,944 in 2022 (net of a liquidation of $1,850 from exiting the pipeline business).
Operating expenses increased $2,164$293 in 20232025 compared to 2022.2024. This increase was primarily the result of increased executive compensation expense.
Other income decreased $6,165 in 2025 as compared to 2024. This net decrease was due to (i) the reduction of interest income of $3,745, and (ii) the prior year receipt of a $2,750 settlement in 2024 (see Note 22 of our consolidated financial statements for further details).
The income tax provision was $165 in 2025 or an effective tax rate of (0.3%) as compared to a provision in 2024 of $792 or an effective tax rate of 4.9%.
The Company's effective tax rate for the years 2025 and 2024 reflects the effect of certain tax credits and incentives. Most notable to the 2025 effective tax rate was the effect of the CFPC, a new 2025 non-refundable, transferable incentive recorded as a reduction in cost of goods sold following International Accounting Standards (“IAS”) 20 principles. The Budget Reconciliation Act of 2025 also reinstated the Small Agri-biodiesel Producer Tax Credit, a non-refundable, transferable incentive similarly recorded as a reduction in cost of goods sold following IAS 20. The reduction in cost of goods sold is excluded from the Company’s taxable income, impacting the effective tax rate.
Other income was $10,015 in 2023 as compared to other expenses of $3,808. During 2023, we exited our position in marketable securities and transferred the funds to interest earning deposits. As a result, interest and dividend income increased $4,707 in 2023 as compared to 2022. The net realized gain on the sale of marketable securities was $575 in 2023 as compared to an unrealized loss of $8,546 in 2022 (see Note 7 of our consolidated financial statements for further details).
The income tax provision was $1 in 2023 or an effective tax rate of 0.0% as compared to a benefit in 2022 of ($1,473) or an effective tax rate of (10.7%).
The Company’smost effective tax rates for the years 2023 and 2022 reflect the positivenotable effect of certain tax credits and incentives,incentives to the most2024 significanteffective tax rate was from the BTC, which expired December 31, 2024. The BTC was also recorded as a reduction in cost of whichgoods aresold thefollowing BTCIAS and the Small Agri-biodiesel Producer Tax Credit.20. Based on technical guidance from the Internal Revenue Service, the Company excludesexcluded the portion of the BTC not used to satisfy excise tax liabilities from income.its Seetaxable Noteincome, 3 to our consolidated financial statements for a discussion ofimpacting the pretaxeffective earningstax impact of the BTC.rate.
The Company’s effective tax rate for 20232025 and 20222024 includes an expense of $6,821$11,558 or 18.2%23.5% and $7,392$8,169 or 53.8%,50.1%, respectively, from the recording of a valuation allowance against its deferred tax assets. The Company evaluates its deferred tax assets and records a valuation allowance to reduce these assets to the amount that is more likely than not to be realized. As of December 31, 2023,2025, based on all available and allowable evidence, the Company determined that its deferred tax assets of $53,400 are more likely than not realizable only to the extent of $19,484, resulting in a net deferred tax liability of $910. As of December 31, 2024, based on all available and allowable evidence, the Company determined that its deferred tax liabilitiesassets andwere recordedmore likely than not realizable only to the extent of $18,691, resulting valuationin allowance.a net deferred tax liability of $773.
For the fiscal year 2025, chemical sales revenue totaled $59,565, a 26% ($20,442) contraction compared to 2024. This downturn was largely driven by operational headwinds, including weather-related complications that extended the scheduled plant turnaround and subsequent slower production rates during the facility restart. These factors, combined with diminished volumes in the energy sector, impacted both primary chemical product lines.
Custom Chemicals
Revenue from our custom manufacturing product line decreased 26% ($17,798) to $51,675 in 2025. This decline was primarily influenced by:
Performance Chemicals
Performance chemicals revenue fell 25% ($2,644) to $7,890 in 2025. Key factors included:
Gross profit for the Chemicals segment decreased by $35,639 in 2025 compared to the prior year. This margin compression was primarily driven by the following factors:
Chemical sales revenue increased 1% or $674 in 2024 compared with 2023. Sales revenue for our custom chemical product line (chemicals produced for specific customers) totaled $69,473, an increase of 8% or $5,187 from 2023. Included in this net increase were higher sales volumes of chemicals sold into the automotive coatings market, sales of one new product into the coatings market, and an increase of $5,492 from the amortization of deferred revenue of a long-term contract which expired. We are working with this customer on a new long-term agreement while we continue to do business. Mostly offsetting these increases were reduced sales prices and volumes of chemicals sold in the agricultural and energy markets. Performance chemicals revenue (comprised of multi-customer products which are sold based on specification) was $10,534 in 2024, a decrease of 30% or $4,513 from 2023. This decrease resulted from lower sales volumes and prices of glycerin products. Sales volumes were negatively impacted by the downtime of production equipment during the last half of 2024 from delays by equipment suppliers.
Gross profit for the chemicals segment decreased 24% or $7,304 in 2024 compared with 2023. This decrease was primarily from: (i) reduced chemical sales prices in the agricultural and energy markets, and (ii) reduced sales volumes as described above. Partially offsetting these decreases were: (i) the benefit of the amortization of deferred revenue in the chemical segment of $5,492, and (ii) the change in the adjustment in the carrying value of our inventory as determined utilizing the LIFO method of inventory accounting. This adjustment increased gross profit $658 in 2024 as compared to $1,920 in 2023.
2023 Compared to 2022
Chemical sales revenue decreased 1.9% or $1,560 in 2023 compared with 2022. Sales revenue for our custom chemical product line (chemicals produced for specific customers) totaled $64,286, an increase of 9.4% or $5,549 from 2022. Included in this net increase was higher sales volumes of chemical intermediates in the oil and gas industry and contractual price increases partially offset by reduced amortization of deferred revenue of $3,081 (see Note 4 of our consolidated financial statements for further details). Performance chemicals revenue (comprised of multi-customer products which are sold based on specification) was $15,047 in 2023, a decrease of 32.1% or $7,109 from 2022. This decrease resulted from lower selling prices of our glycerin products partially offset by higher volumes.
Gross profit for the chemicals segment increased 16.7% or $4,291 in 2023 compared with 2022. This improvement was primarily from the change in adjustments in the carrying value of our inventory as determined utilizing the last-in, first-out (“LIFO”) method of inventory accounting which increased gross profit $1,920 in 2023 and decreased gross profit $1,093 in 2022. Also contributing to this increase was stronger margins and higher sales volumes in products sold into the oil and gas industry. Partially reducing these improvements was the change in the timing of deferred revenue amortization of $3,081 and lower margins from glycerin products on reduced selling price from increased imports.
BiofuelBiofuels Segment
Biofuels sales revenue decreased 78% in 2025 compared to 2024. This contraction was primarily driven by a 75% reduction in sales volume and a 3% decline in the average selling price of fuel, inclusive of D4 RIN values.
The decline in performance is attributable to an extended plant turnaround initiated to enhance long-term reliability, followed by the subsequent strategic decision to idle production due to regulatory uncertainty surrounding the CFPC and other adverse market conditions.
Customer Concentration and Market Dynamics. Historically, a portion of our biodiesel output was sold to two major United States refiners. In 2025, however, we had no major customers with revenue greater than 10%.
Biofuels Gross Profit Analysis. Gross profit for the Biofuels segment decreased by $23,430 in 2025 compared to 2024. The primary drivers of this variance include:
Biofuels sales revenue decreased 43% in 2024 compared to 2023, primarily from a 21% reduction in sales volume and a 23% reduction in the average price of fuel sold inclusive of D4 RIN prices. Production and sales volumes in 2024 were impacted by the extreme winter weather experienced in the first quarter as well as production issues, stemming from delays by equipment suppliers that created an extended service utility downtime, which impacted the third and fourth quarter.
A portion of our biodiesel sold was to two major refiners in the United States in 2024 and 2023. No assurances can be given that we will continue to sell to such major refiners, or, if we do sell, the volume we will sell or the profit margin we will realize. We do not believe that the loss of this customer would have a material adverse effect on our biofuels segment or on us as a whole in that: (i) unlike our custom manufacturing products, biodiesel is a commodity with a large potential customer base; (ii) we believe that we could readily sell our biodiesel to other customers as potential demand from other customers for biodiesel exceeds our production capacity; (iii) our sales to this customer are not under fixed terms and the customer has no fixed obligation to purchase any minimum quantities except as stipulated by short term purchase orders; and (iv) the prices we receive from this customer are based upon then-market rates, as would be the case with sales of this commodity to other customers.
Biofuels gross profit decreased $14,031 in 2024 compared to 2023. This decrease primarily resulted from reduced sales volumes, primarily stemming from: (i) extreme winter weather in the first quarter of 2024, (ii) delays by equipment suppliers that created an extended service utility downtime, which prevented us from building the biodiesel inventories we would typically have available to sell in the last half of 2024, and (iii) the change in the unrealized activity of derivative instruments in comparison to the prior year with a loss of $1,971 in the current year and a gain of $1,878 in the prior year. Also reducing gross profit was the change in the adjustment in the carrying value of our inventory as determined utilizing the LIFO method of inventory accounting. This adjustment increased gross profit $2,370 in 2024 as compared to an increase in gross profit of $8,414 in 2023.
2023 Compared to 2022
Biofuels sales revenue decreased 8.3% or $26,204 in 2023 compared to 2022, primarily from decreased selling prices of biodiesel and biodiesel blends, inclusive of a decline in separated RIN sale prices. RIN prices declined during 2023 as production levels exceeded the renewable volume obligations set by the EPA.
A portion of our biodiesel sold was to two major refiners in the United States in 2023 and 2022. No assurances can be given that we will continue to sell to such major refiners, or, if we do sell, the volume we will sell or the profit margin we will realize. We do not believe that the loss of this customer would have a material adverse effect on our biofuels segment or on us as a whole in that: (i) unlike our custom manufacturing products, biodiesel is a commodity with a large potential customer base; (ii) we believe that we could readily sell our biodiesel to other customers as potential demand from other customers for biodiesel exceeds our production capacity; (iii) our sales to this customer are not under fixed terms and the customer has no fixed obligation to purchase any minimum quantities except as stipulated by short term purchase orders; and (iv) the prices we receive from this customer are based upon then-market rates, as would be the case with sales of this commodity to other customers.
Biofuels gross profit increased $7,695 in 2023 compared to 2022. Gross profit primarily increased from the prior year from: (i) the change in the realized activity of derivative instruments in comparison to the prior year with a gain of $694 as compared to a loss of $24,360 in the prior year; the prior year was unfavorably impacted by the volatility in the NYMEX heating oil futures market which generated realized losses of $10,500 and (ii) the change in the unrealized activity of derivative instruments in comparison to the prior year with a gain of $1,878 in the current year and a gain of $343 in the prior year. Also improving gross profit was the change in adjustments in the carrying value of our inventory as determined utilizing the LIFO method of inventory accounting increased gross profit $8,414 in 2023 as compared to a decrease in gross profit of $5,794 in 2022. In 2022, the liquidation effect of exiting the pipeline business increased gross profit $1,851 in 2022; no such liquidation occurred in 2023.
The determination of an asset's useful life is a fundamental estimate that impacts our financial results. We primarily establish these estimates based on historical experience with similar assets. However, the actual useful life may vary significantly from these projections due to several factors:
What changed in the latest 10-Q
Risk Factors
There have been no material changes to risk factors; however, due to the uncertainty of the current economic environment, we encourage reference to the risk factors previously disclosed in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025.
No wording changes found in this section.
Full comparison: every changed paragraph (0)
Management's Discussion & Analysis (MD&A)
New heading “* Adjusted to reflect the change in accounting methodology from LIFO to moving average for inventory valuation. See Note 1 to our consolidated financial statements for additional information.”
Removed heading “Income tax provision”
Largest changes
“* Adjusted to reflect the change in accounting methodology from LIFO to moving average for inventory valuation. See Note 1 to our consolidated financial statements for additional information.”see in full comparison
Biofuel grosssee in full comparisonlossprofitwasincreased$13,339$23,594 and $19,428 in the three and six months endedMarchJune31,30, 2026,representing an increase of $4,166respectively, compared to the sameperiodperiods in 2025.ThisTheseincreasedincreaseslosswere primarily due to regulatory clarity which improved the segment on both volume and margin inclusive of clarified guidelines on the CFPC. During the quarter, this increase wasprimarilyalso partially driven byunfavorablefavorable shifts in derivative instruments activity.DuringIn thequarter,three months ended June 30, 2026, we recognized a realized loss of$9,141$1,383 and an unrealizedlossgain of$2,488,$3,223 compared to a realized gain of$93$77 and an unrealizedlossgain of$259$540 in the prior-year period. While the$9,141$1,383 in derivative settlementssignificantlyimpacted the currentquarter’speriod’s grossloss,profit, these costs are generally intended to be recovered once the underlying physical product is sold. This timing difference often creates a temporary disconnect between realized derivative losses and the eventual revenue recognition of the physical inventory. During the six-month period ended June 30, 2026, gross profit increases were partially offset by unfavorable shifts in derivative activity. In the six months ended June 30, 2026, we recognized a realized loss of $10,523 and an unrealized gain of $735, compared to a realized gain of $170 and an unrealized gain of $281 in the prior year period.
“Chemical revenue in the six months ended June 30, 2026, increased 75% or $ 19,497 compared to the six months ended June 30, 2025. Revenue from custom chemicals for the six months ended June 30, 2026 totaled $32,391, a net increase of $9,732 from the same period in 2025, primarily resulting from higher sales volumes of products sold in the energy market of $8,508. Performance chemicals revenue was $13,090, an increase of $9,765 from the six months ended June 30, 2025 from sales of the new energy market product brought online in the fourth quarter of 2025.”see in full comparison
“On June 30, 2026, the Company contracted with Freepoint Commodities to sell its 2025 CFPC and Small Agri-Biodiesel Producer Tax Credits which were $2,725 net of fees. The Company recognized a receivable for the 2025 credits. The Company also committed to sell its 2026 credits which were $6,733 as of June 30, 2026. The 2026-2029 tax credits will be monetized at each fiscal year end with an early draw provision subject to financing fees.”see in full comparison
Operating expenses increasedsee in full comparison$710$611 in the three months endedMarchJune31,30, 2026, as compared to the three months endedMarchJune31,30, 2025. The net increase was primarily fromwinteradditionalstormexpenditures related to Winter Storm Fernfreezeof $260 and $281 for expenses incurred from a fire which was safely and quickly contained. Operating expenses increased $1,321 in the six months ended June 30, 2026, as compared to the six months ended June 30, 2025. The net increase was primarily from extraordinary maintenance and repair expenses of$1,357,$1,898, partially offset by reduced compensation and research and development expenses.
Full comparison: every changed paragraph (25)
The biodiesel segment was supported by the United States Environmental Protection Agency (“EPA”) Renewable Fuel Standard (“RFS”). We generate 1.5 Renewable Identification Numbers (“RINs”) for each gallon of biodiesel sold in the United States with a classification of a D4 or D6 RIN. RINs are used to monitor the level of renewable fuel traded in a given year in accordance with RFS within the EPA moderated transaction system. We do not assign cost of goods sold to the generation of RINs as the physical fuel generates the full cost. As of MarchJune 31,30, 2026, we held 0.20.1 million D4 RINs with a fair market value of $298.$210. Comparatively, as of MarchJune 31,30, 2025, we held 2.30.5 million D4 RINs with a fair market value of $2,077.$604.
On February 4, 2026, the Treasury Department and the Internal Revenue Service issued proposed regulations providing expanded guidance on the clean fuel production credit (“CFPC”) integrating changes from the Budget Reconciliation Act of 2025, which made modifications to the CFPC. The proposed rule is expected to help level the competitive environment for biodiesel by: (i) reducing the tax credit for sustainable aviation fuel from $1.75 per gallon to $1.00 per gallon effective January 1, 2026, and (ii) requiring that all feedstock be sourced from North America, as required for biomass-based diesel. On June 12, 2026, the Department of Energy released the updated 45ZCF-GREET model to help biofuel producers calculate carbon intensity for the CFPC.
On June 30, 2026, the Company contracted with Freepoint Commodities to sell its 2025 CFPC and Small Agri-Biodiesel Producer Tax Credits which were $2,725 net of fees. The Company recognized a receivable for the 2025 credits. The Company also committed to sell its 2026 credits which were $6,733 as of June 30, 2026. The 2026-2029 tax credits will be monetized at each fiscal year end with an early draw provision subject to financing fees.
* Adjusted to reflect the change in accounting methodology from LIFO to moving average for inventory valuation. See Note 1 to our consolidated financial statements for additional information.
The following table reconciles net income (loss) income,, the most directly comparable GAAP performance financial measure, with adjusted EBITDA.
Consolidated revenue in the three months ended MarchJune 31,30, 2026, increased 82%121% or $14,414$43,053 compared to the three months ended MarchJune 31,30, 2025, primarily driven by two factors:
Consolidated revenue in the six months ended June 30, 2026, increased 108% or $57,467 compared to the six months ended June 30, 2025. The change in volume and product mix of $25,250 was largely due to growth in the chemical segment's energy market products adding $17,427 as noted above. The biofuel segment added $7,823 from energy market performance and regulatory clarity.
Gross profit (loss) in the three and six months ended MarchJune 31,30, 2026, increasedimproved $670$27,416 and $26,746, respectively, as compared to the same periodperiods of 2025. This variance was primarily driven by twogrowth factors:in the chemical segment, energy regulatory clarity in the biofuel segment, and energy market performance in both segments.
Operating expenses increased $710$611 in the three months ended MarchJune 31,30, 2026, as compared to the three months ended MarchJune 31,30, 2025. The net increase was primarily from winteradditional stormexpenditures related to Winter Storm Fern freezeof $260 and $281 for expenses incurred from a fire which was safely and quickly contained. Operating expenses increased $1,321 in the six months ended June 30, 2026, as compared to the six months ended June 30, 2025. The net increase was primarily from extraordinary maintenance and repair expenses of $1,357,$1,898, partially offset by reduced compensation and research and development expenses.
Other income, net decreased $932$1,359 in the three months ended MarchJune 31,30, 2026, as compared to the same period of 2025, primarily from the reduction in interest income. In the current three-month period interest income was $209 as compared to $1,068 in the prior period. Other income, net decreased $2,291 in the six months ended June 30, 2026, as compared to the same period of 2025 primarily from the reduction ofin interest income. In the current three-monthsix-month period interest income was $298$507 as compared to $1,237$2,305 in the prior period.
Income tax provision
The Company’s income tax provision for the three and six months ended MarchJune 31,30, 2026,2026 isand 2025, was comprised primarily of an increase in the valuation allowance against net deferred assets, plus immaterial state taxes and miscellaneous items. The income tax benefit for the three months ended March 31, 2025, was comprised of immaterial state taxes and miscellaneous items.
Chemical revenue in the three months ended MarchJune 31,30, 2026, increased 110%56% or $10,267$9,230 compared to the three months ended MarchJune 31,30, 2025. Revenue from custom chemicals for the three months ended MarchJune 31,30, 2026 totaled $13,872,$18,519, a net increase of $5,463$4,269 from the same period in 2025, primarily resulting from higher sales volumes of products sold in the energy market of $4,405.$4,103. Performance chemicals revenue was $5,760,$7,330, an increase of $4,804$4,961 from the three months ended MarchJune 31,30, 2025 from sales of a new energy market product brought online in the fourth quarter of 2025.
Chemical revenue in the six months ended June 30, 2026, increased 75% or $ 19,497 compared to the six months ended June 30, 2025. Revenue from custom chemicals for the six months ended June 30, 2026 totaled $32,391, a net increase of $9,732 from the same period in 2025, primarily resulting from higher sales volumes of products sold in the energy market of $8,508. Performance chemicals revenue was $13,090, an increase of $9,765 from the six months ended June 30, 2025 from sales of the new energy market product brought online in the fourth quarter of 2025.
Gross lossprofit for the chemical segment was $2,519$4,937 and $2,418 for the three and six months ended MarchJune 31,30, 2026, respectively, an improvement of $3,496$3,823 and $7,319, respectively, compared to the same periodperiods of 2025. The improvement was primarily driven by newincreased productsales revenuevolumes sold intoin the energy market asincluding notedthe above.new product revenue brought online in the fourth quarter of 2025.
Biofuels revenue in the three and six months ended MarchJune 31,30, 2026, increased by$ $4,14733,823 and $37,970, respectively, compared to the prior-year period.periods. The upward trend was primarily attributed to enhanced clarity surrounding the CFPC and record-high final renewable volume obligation (“RVO”) levels. However, these gains were partially offset by lower sales volumes, which were adversely impacted by severe winter weatherlevels, and geopoliticalto instabilitya lesser degree, increased equipment utilization following an extended turnaround in the fuelprior marketsyear, duesix-month to the war with Iran.period.
A significant portion of our biodiesel sold was to onetwo major customercustomers in both the three and six months ended MarchJune 31,30, 2026, as compared to nothree and two major customers in the three and six months ended MarchJune 31,30, 2025.2025, respectively. No assurances can be given that we will continue to sell to any such major refiner, or, if we do sell, the volume we will sell or the profit margin we will realize. We do not believe that the loss of these customers would have a material adverse effect on our biofuels segment or on us as a whole because: (i) we believe that we could readily sell our biodiesel to other customers on equivalent terms as potential demand from other customers for biodiesel exceeds our production capacity; (ii) our sales to these customers are not under fixed terms and the customers have no fixed obligation to purchase any minimum quantities except as stipulated by short-term purchase orders; and (iii) the prices we receive from these customers are based upon then-market rates, as would be the case with sales of this commodity to other customers.
Biofuel gross lossprofit wasincreased $13,339$23,594 and $19,428 in the three and six months ended MarchJune 31,30, 2026, representing an increase of $4,166respectively, compared to the same periodperiods in 2025. ThisThese increasedincreases losswere primarily due to regulatory clarity which improved the segment on both volume and margin inclusive of clarified guidelines on the CFPC. During the quarter, this increase was primarilyalso partially driven by unfavorablefavorable shifts in derivative instruments activity. DuringIn the quarter,three months ended June 30, 2026, we recognized a realized loss of $9,141$1,383 and an unrealized lossgain of $2,488,$3,223 compared to a realized gain of $93$77 and an unrealized lossgain of $259$540 in the prior-year period. While the $9,141$1,383 in derivative settlements significantly impacted the current quarter’speriod’s gross loss,profit, these costs are generally intended to be recovered once the underlying physical product is sold. This timing difference often creates a temporary disconnect between realized derivative losses and the eventual revenue recognition of the physical inventory. During the six-month period ended June 30, 2026, gross profit increases were partially offset by unfavorable shifts in derivative activity. In the six months ended June 30, 2026, we recognized a realized loss of $10,523 and an unrealized gain of $735, compared to a realized gain of $170 and an unrealized gain of $281 in the prior year period.
Revenue from bill-and-hold transactions in which a performance obligation exists is recognized when the total performance obligation has been met and control of the product has transferred. Bill-and-hold transactions for the three and six months ended MarchJune 31,30, 2026 and 2025 were related to custom chemicals customers whereby revenue was recognized in accordance with contractual agreements based upon product being produced and ready for use by the customer. These sales were subject to written monthly purchase orders. The product was custom manufactured and stored at the customer’s request and could not be sold to another buyer. Credit and payment terms for bill-and-hold customers are similar to other custom chemicals customers. Revenues under bill-and-hold arrangements were $10,378$13,027 and $23,405 for the three and six months ended MarchJune 31,30, 2026. As of MarchJune 31,30, 2026 and December 31, 2025, $5,486$4,357 and $5,106 of bill-and-hold revenue had not shipped, respectively.
Our net cash from operating activities, investing activities, and financing activities for the threesix months ended MarchJune 31,30, 2026 and 2025 is set forth in the following table.
Cash used in operating activities was $19,996$1,227 in the threesix months ended MarchJune 31,30, 2026, as compared to $5,395$183 in the same period of 2025. This increase in cash used was primarily attributable to the change in inventory of $26,609 and the change in accounts receivable, including accounts receivable - related parties resulting in a cash outflow of $17,891.$21,643. Also contributing to the current period's increase in cash used was the change in deferred revenue of $3,666, the change in accrued expenses and other current liabilities of $2,842.$2,429, and the change in other assets of $1,698. Partially offsetting these cash outflows was the change in net income of $23,072, the change in accounts payable, including accounts payable - related parties, resulting in a cash inflow of $4,432,$16,564, and the change in inventoryother noncurrent liabilities of $3,359.$14,970.
Cash used in investing activities was $6,321$12,652 in the threesix months ended MarchJune 31,30, 2026, as compared to $4,082$8,585 in the threesix months ended MarchJune 31,30, 2025. This $2,239$4,067 increase in cash used was primarily due to an increase in capital expenditure of $1,384.$3,900.
Cash used in financing activities was $2,632$3,071 and $2,993$5,621 in the threesix months ended MarchJune 31,30, 2026 and 2025, respectively, primarily for payments of dividends on our common stock.
Regular cash dividends of $0.06 per share were paid on our common stock in each quarter of 2025. The declaration of these regular quarterly cash dividends was made in the three months ended December 31, 2024. During the three months ended DecemberMarch 31, 2025,2026, a declaration for cash dividends of $0.06$0.01 per share was made for the firstsecond quarter of 2026. The cash dividenddividends in the three months ended MarchJune 31,30, 2026 and 2025, amounted to $2,628$439 and $2,632,$2,628, respectively. During the three months ended MarchJune 31,30, 2026, a cash dividend of $0.01 per share was declared for the secondthird quarter of 2026.
We engage in two types of transactions to mitigate the impacts of changes in prices for both commodity sales and purchases. First, for our biofuel sales, we enter into the purchase and sale of futures contracts and options on futures contracts of energy commodities. This activity was captured in our consolidated balance sheets at MarchJune 31,30, 2026, and December 31, 2025 as derivative instruments recorded in accordance with ASC 815. Second, for our biofuel feedstocks, we execute purchase contracts and supply agreements with certain vendors that meet the normal purchase and normal sales exception of ASC 815. These transactions are recognized in earnings and were not recorded in our consolidated balance sheets at MarchJune 31,30, 2026, or December 31, 2025 to the extent that we are able to apply the normal purchase and normal sales exception of ASC 815. The purchase of biofuels feedstock generally involves two risk components: basis and price. Basis covers any refining or processing required as well as transportation. Price covers the purchases of the actual agricultural commodity. Both basis and price fluctuate over time. A supply agreement with a vendor constitutes a hedge when we have committed to a certain volume of feedstock in a future period and have fixed the basis for that volume.
FF insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 1 Form 4 filing (1 insider, 1 trade date, 10,000 shares, about $42.8K) and open-market sales in 0 filings. Net open-market shares: 10,000 (purchases minus sales); net value about $42.8K.Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
| Trade date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-04 | Polet Roeland |
Open-market purchase | 10,000 | $4.28 | $42.8K |
Well-known investors holding FF (13F)
| Investor | Quarter | Shares | Reported value | % of their 13F | Change vs prior quarter |
|---|---|---|---|---|---|
| Renaissance Technologies | 2026-06-30 | 1,433,400 | $6.5M | 0.01% | Reduced 9% |
| Two Sigma Investments | 2026-06-30 | 782,079 | $3.5M | 0.0% | Reduced 6% |
| Citadel Advisors (Ken Griffin) | 2026-06-30 | 540,985 | $2.4M | 0.0% | Added 40% |
| AQR Capital Management (Cliff Asness) | 2026-06-30 | 433,132 | $2.0M | 0.0% | Added 177% |
| Millennium Management (Israel Englander) | 2026-06-30 | 411,870 | $1.9M | 0.0% | New position |
| D. E. Shaw & Co. | 2026-06-30 | 146,607 | $662.7K | 0.0% | Reduced 20% |
| Point72 Asset Management (Steve Cohen) | 2026-06-30 | 55,149 | $249.3K | 0.0% | New position |